The natural history of chronic hepatitis B virus infection

Seminars in Liver Disease

Volumn 24, Issue SUPPL. 1, 2004, Pages 17-21

  McMahon, Brian J ^a,b  

^a Alaska Native Medical Center ^*  (United States)

^b ALASKA NATIVE MEDICAL CENTER   (United States)

Author keywords

Hepatitis B virus; Hepatocellular carcinoma; Natural history

Indexed keywords

AMINOTRANSFERASE; ANTIVIRUS AGENT; HEPATITIS B VACCINE; HEPATITIS B(E) ANTIGEN; VIRUS DNA;

AGE; AMINOTRANSFERASE BLOOD LEVEL; CHRONIC HEPATITIS; CONFERENCE PAPER; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS DELTA VIRUS; HISTORY; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOPROPHYLAXIS; INFECTION PREVENTION; INFECTION RISK; LIVER BIOPSY; LIVER CELL CARCINOMA; MASCULINITY; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RISK FACTOR; VIRUS CARRIER; VIRUS GENOME;

ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; CARCINOMA, HEPATOCELLULAR; DISEASE PROGRESSION; GENOTYPE; HEPATITIS B E ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LIVER NEOPLASMS; RISK FACTORS;

EID: 2942596233     PISSN: 02728087     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-828674     Document Type: Conference Paper

References (19)

1. Lok AS, McMahon BJ. Chronic hepatitis B: update of recommendations. AASLD Practice Guideline. Hepatology 2004;39:857-861
2. Lok AS, Heathcote EJ, Hoofnagle JH. Management of hepatitis B: 2000. Summary of a workshop. Gastroenterology 2001;120:1828-1853
3. Lee PI, Chang MH, Lee CY, et al. Changes in serum hepatitis B DNA and aminotransferase levels during the course of chronic hepatitis B virus infection in children. Hepatology 1990;12:657-660
4. Bortolotti F, Cadrobbi P, Crivellaro C, et al. Long-term outcome of chronic type B hepatitis in patients who acquire hepatitis B infection in childhood. Gastroenterology 1990;99:805-810
5. McMahon BJ, Holck P, Bulkow L, Snowball MM. Serologic and clinical outcomes of 1536 Alaska natives chronically infected with hepatitis B virus. Ann Intern Med 2001;135:759-768
6. Hadziyannis SJ, Vassilopoulos D. Immunopathogenesis of hepatitis B e antigen negative chronic hepatitis B infection. Antiviral Res 2001;52:91-98
7. Brunetto MR, Oliveri F, Rocca G, et al. Natural course and response to interferon of chronic hepatitis B accompanied by antibody to hepatitis B e antigen. Hepatology 1989;10:198-202
8. Okamoto H, Tsuda F, Akahane Y, et al. Hepatitis B virus with mutations in the core promoter for an e antigen-negative phenotype in carriers with antibody to e antigen. J Virol 1994;68:8102-8110
9. McMahon BJ. Chronic carriers of hepatitis B virus who clear hepatitis B surface antigen: are they really "off the hook?" Hepatology 1998;28:265-267
10. Harpaz R, McMahon BJ, Margolis HS, et al. Elimination of new chronic hepatitis B virus infections: results of the Alaska immunization program. J Infect Dis 2000;181:413-418
11. Chang MH, Chen CJ, Lai MS, et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. N Engl J Med 1997;336:1855-1859
12. Chu CJ, Keeffe EB, Han SY, et al. Hepatitis B virus genotypes in the United States: Results of a nationwide study. Gastroenterology 2003;125:444-451
13. Koa JH, Chen PJ, Lai MY, Chen DS. Genotypes and clinical phenotypes of hepatitis B virus in patients with chronic hepatitis B virus infection. J Clin Microbiol 2002;40:1207-1209
14. Sumi H, Yokosuka O, Seki N, et al. Influence of hepatitis B virus genotypes on the progression of chronic hepatitis B liver disease. Hepatology 2003;37:19-26
15. Chu CJ, Lok ASF. Clinical significance of hepatitis B virus genotypes. Hepatology 2002;35:1274-1276
16. Chu CJ, Keeffe EB, Han SY, et al. Prevalence of HBV precore/core promoter variants in the United States. Hepatology 2003;38:619-628
17. Hadziyannis SJ, Papatheodoridis GV, Vassilopoulos D. Precore mutant chronic hepatitis B-approach to management. Medscape Gen Med Gastroenterology 2003;4:1-12. Available at: www.medscape.com/viewarticle/459763 Accessed November 4, 2003
18. McMahon BJ, Bulkow L, Harpster A, et al. Screening for hepatocellular carcinoma in Alaska natives infected with chronic hepatitis B: a 16-year population-based study. Hepatology 2000;32:842-846
19. Farci P. Delta hepatitis: an update. J Hepatol 2003;39:S212-S219